| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Departments of Medical Oncology and Experimental Therapeutics [B. I. C.] and Cytogenetics and Cytology [I. H.], City of Hope National Medical Center, Duarte, California 91010, and Departments of Cell Biology, Mayo Clinc/Foundation [E. L. B., H. L. M.], Rochester, Minnesota 55901
Platelet-derived type ß transforming growth factor (TGFß) is a potent inhibitor of DNA synthesis in primary monolayer cultures of adult rat hepatocytes. TGFß induced a 50% inhibition of epidermal growth factor (EGF)-mediated DNA synthesis at approximately 5 x 1012 M. This inhibition did not appear to be due to a delay in the peak of DNA synthesis or a toxic action, nor could it be overcome by increasing concentrations of the mitogens EGF, insulin, or glucagon. Inhibition was observed either when TGFß and EGF were continuously present together in the culture medium or when TGFß was added to the hepatocyte cultures after removal of the EGF stimulant. This observation together with a lack of an inhibitory effect of TGFß on the binding of 125I-labeled EGF to hepatocytes in culture, suggests that the inhibitory action of TGFß was not caused by a direct competition with EGF at the cell surface. TGFß could not inhibit DNA synthesis once it had begun; however, the inhibitory action of TGFß could be partially overcome by increasing amounts of conditioned medium produced by normal hepatocytes. Specific saturable receptors for TGFß were found on the normal rat hepatocytes, but specific binding could not be detected on hepatocytes from regenerating liver. TGFß is thus a potent inhibitor of EGF-induced DNA synthesis in adult rat hepatocytes. Its significance for growth control in vivo has yet to be assessed.
1 Support for this work was provided in part by USPHS Grants CA-433572 and CA 27217 from the National Cancer Institute.
2 To whom requests for reprints should be addressed, at Department of Medical Oncology, City of Hope Medical Center, 1500 E. Duarte Road, Duarte, CA 91010.
Received 10/15/85. Revised 2/ 6/86. Accepted 2/ 7/86.
This article has been cited by other articles:
![]() |
H.-N. Chen, S. Fan, and C.-F. Weng Down-regulation of TGF{beta}1 and leptin ameliorates thioacetamide-induced liver injury in lipopolysaccharide-primed rats Innate Immunity, June 1, 2007; 13(3): 176 - 188. [Abstract] [PDF] |
||||
![]() |
W. Ju, A. Ogawa, J. Heyer, D. Nierhof, L. Yu, R. Kucherlapati, D. A. Shafritz, and E. P. Bottinger Deletion of Smad2 in Mouse Liver Reveals Novel Functions in Hepatocyte Growth and Differentiation Mol. Cell. Biol., January 15, 2006; 26(2): 654 - 667. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kar, M. Wang, K. S. Rosi, C. S. Wilcox, and B. I. Carr Inhibition of rat liver regeneration after partial hepatectomy and induction of ERK phosphorylation by Cpd 5, a K vitamin-based anticancer compound Carcinogenesis, December 1, 2004; 25(12): 2345 - 2351. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. A. Iocca and H. C. Isom Tumor Necrosis Factor-{alpha} Acts as a Complete Mitogen for Primary Rat Hepatocytes Am. J. Pathol., August 1, 2003; 163(2): 465 - 476. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Macias-Silva, W. Li, J. I. Leu, M. A. S. Crissey, and R. Taub Up-regulated Transcriptional Repressors SnoN and Ski Bind Smad Proteins to Antagonize Transforming Growth Factor-beta Signals during Liver Regeneration J. Biol. Chem., August 2, 2002; 277(32): 28483 - 28490. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. Lau, T. R. Kumar, K. Nishimori, J. Bonadio, and M. M. Matzuk Activin beta C and beta E Genes Are Not Essential for Mouse Liver Growth, Differentiation, and Regeneration Mol. Cell. Biol., August 15, 2000; 20(16): 6127 - 6137. [Abstract] [Full Text] |
||||
![]() |
M Date, K Matsuzaki, M Matsushita, Y Tahashi, F Furukawa, and K Inoue Modulation of transforming growth factor beta function in hepatocytes and hepatic stellate cells in rat liver injury Gut, May 1, 2000; 46(5): 719 - 724. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Low-Baselli, K. Hufnagl, W. Parzefall, R. Schulte-Hermann, and B. Grasl-Kraupp Initiated rat hepatocytes in primary culture: a novel tool to study alterations in growth control during the first stage of carcinogenesis Carcinogenesis, January 1, 2000; 21(1): 79 - 86. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Qi, N. Atsuchi, A. Ooshima, A. Takeshita, and H. Ueno Blockade of type beta transforming growth factor signaling prevents liver fibrosis and dysfunction in the rat PNAS, March 2, 1999; 96(5): 2345 - 2349. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Braghiroli, B. Silvestrini, C. Sorrentino, J. Grima, D. Mruk, and C. Yan Cheng Regulation of {alpha}2-Macroglobulin Expression in Rat Sertoli Cells and Hepatocytes by Germ Cells In Vitro Biol Reprod, July 1, 1998; 59(1): 111 - 123. [Abstract] [Full Text] |
||||
![]() |
G. K. Michalopoulos and M. C. DeFrances Liver Regeneration Science, April 4, 1997; 276(5309): 60 - 66. [Abstract] [Full Text] |
||||
![]() |
P. Peron, M. Rahmani, Y. Zagar, A.-M. Durand-Schneider, B. Lardeux, and D. Bernuau Potentiation of Smad Transactivation by Jun Proteins during a Combined Treatment with Epidermal Growth Factor and Transforming Growth Factor-beta in Rat Hepatocytes. ROLE OF PHOSPHATIDYLINOSITOL 3-KINASE-INDUCED AP-1 ACTIVATION J. Biol. Chem., March 23, 2001; 276(13): 10524 - 10531. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |